TGA Advises on Recent Recalls

26 May 2016

The TGA has recently advised consumers and health professionals that GlaxoSmithKline Consumer Healthcare Australia is in the process of recalling three batches of Children’s Panadol 5-12 years suspension and Nipro Australia one batch of TRUEresult blood glucose test strips.

The batches of 200 ml bottles of Children’s Panadol are being recalled because it has been identified that an ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres. The quantity of these particles would be small and they may not be visible in the product. If this occurs, there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time.

The affected batch numbers are:

  • 136418 (strawberry flavour)
  • 136444 (strawberry flavour)
  • 136443 (orange flavour)

The expiry date for each of the recalled products is February 2018.

The batch of 10 pack TRUEresult blood glucose test strips is being recalled because of a risk of the strips giving incorrect readings. The affected batch number is KS1741, with expiry date 25/06/2018.

More info on Recall: Children's Panadol 5-12 years suspension 200 mL bottle

More info on Recall: TRUEresult blood glucose test strips